bibliographicCitation |
Bogatkevich GS, Highland KB, Akter T, Silver RM. The PPARγAgonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects. Pulmonary Medicine. 2012;2012():1–9. doi: 10.1155/2012/545172. |